Original title:&nbsp;5 Years Experience With Trancatheter Tranaspical Mitral Valve &ndash;in Valve Implantation for Bioprosthetic Valve Dysfunction&nbsp;Reference:&nbsp;Anson Cheung et al. J Am Coll Cardiol 2013;61:1759&ndash;66. Percutaneous valves development, first aortic and now mitral, has brought an opportunity to improve life quality and extend life for high risk non-surgical patients. 23 patients received transapical implantation in mitral<a href="https://solaci.org/en/2013/04/29/valve-in-valve-implantation-is-possible/" title="Read more" >...</a>

Original title:&nbsp;Transcatheter Aortic Valve Implantation With the Edwards SAPIEN Versus the Medtronic CoreValve Revalving System Devices. A Multicenter Collaborative Study: The PRAGMATIC Plus Initiative (Pooled-RotterdAm-Milano-Toulouse In Collaboration).&nbsp;Reference:&nbsp;Alaide Chieffo et al. J Am Coll Cardiol 2013;61:830&ndash;6. Since the introduction of percutaneous aortic valve replacement (TAVR), two devices have been widely used. For one side, the self-expanding<a href="https://solaci.org/en/2013/03/10/corevalve-versus-edwards-equivalent-results-at-one-year/" title="Read more" >...</a>

Original title:&nbsp;Trends in outcome after transfemoral transcatheter aortic valve implantation. Pooled-RotterdAm-Milano-Toulouse In Collaboration Plus (PRAGMATICPlus) initiative.&nbsp;Reference:&nbsp;Nicolas M. Van Mieghem et al. Am Heart J 2012;0:1-10. Article in press. Since its introduction in 2002, Transfemoral Transcatheter Aortic Valve Implantation (TAVI) has turned into a viable and safe strategy to treat patients with severe acute stenosis and<a href="https://solaci.org/en/2013/01/15/transfemoral-transcatheter-aortic-valve-implantation-more-experience-and-better-results/" title="Read more" >...</a>

Original title: Valve-in-Valve Implantation of Medtronic CoreValve Prosthesis in Patients with Failing Bioprosthetic Aortic Valves. Reference: Axel Linke el al. Circ Cardiovasc Interv. 2012;5:689-697. This study evaluates the safety, feasibility and results of Core Valve implants on patients with bioprostheses dysfunctional by stenosis, insufficiency or a combination of both. Biological prostheses are preferred over mechanical ones for patients<a href="https://solaci.org/en/2012/11/02/the-largest-published-series-of-valve-in-valve-with-core-valve-medtronic/" title="Read more" >...</a>

Reference:&nbsp;Buellesfeld y colaboradores (JACC in press). Percutaneous aortic valve replacement (AVR) is an innovative technique for the treatment of severe aortic stenosis (SAS); this technique has been incorporated with great enthusiasm in clinical practice, particularly for patients with excessive surgical risks. Due to the proximity of the aortic valve, AV node and His bundle, there<a href="https://solaci.org/en/2012/10/01/the-impact-of-permanent-pacemaker-implantation-in-patients-undergoing-percutaneous-aortic-valve-replacement/" title="Read more" >...</a>

Reference: Durand E. et al (JACC CV interventions 2012 in press)1 When percutaneous aortic valve replacement (AVR) first began the procedure required a large-bore sheath (22-24 F), being the most frequent surgical strategy when using general anesthesia. Continuous technological advances achieved the miniaturization of devices which allow the procedure to be performed with a much<a href="https://solaci.org/en/2012/10/01/aortic-transfemoral-valve-replacement-using-edwards-sapien-and-edwards-sapien-xt-prosthesis-local-anesthesia/" title="Read more" >...</a>